Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

Get detailed information on Olaparib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from the CDSCO, ...

Olaparib monotherapy may be a treatment option for some patients with high-risk biochemically recurrent prostate cancer, according to researchers.

Credit: Professor Johann de Bono, The Institute of Cancer Research, London. Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

In a regulatory filing, the company said it has received permission from the Central Drugs Standard Control Organisation ...

The Central Drugs Standard Control Organisation granted approval for the drug's use in combination with Durvalumab for the ...

This approval establishes the use of Olaparib in combination with Durvalumab as a maintenance treatment for adult patients ...

Olaparib in combination with Durvalumab is indicated for the maintenance treatment of adult patients with advanced or ...